A review of major Crohn's disease susceptibility genes and their role in disease pathogenesis

Genes and Genomics

Volumn 33, Issue 4, 2011, Pages 317-325

  Barrett, Meghan ^a   Chandra, Sathees B ^a  

^a ROOSEVELT UNIVERSITY   (United States)

Author keywords

ATG16L1; Crohn's disease; Genetics; IBD5 locus; IL23R; NOD2

Indexed keywords

BACTERIA (MICROORGANISMS);

EID: 80052627277     PISSN: 19769571     EISSN: 20929293     Source Type: Journal    
DOI: 10.1007/s13258-011-0076-3     Document Type: Review

References (88)

1. Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD et al. (2008) Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat. Gen. 40:955-962
2. Berg DJ, Davidson N, Kühn R, Müller W, Menon S, Holland G, Thompson-Snipes L, Leach MW, Rennick D (1996) Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4 (+) TH1-like responses. J. Clin. Invest. 98:1010-20. (Pubitemid 26293320)
3. Beutler B (2001) Autoimmunity and Apoptosis: the Crohn's connection. Immunity 15:5-14. (Pubitemid 32728315)
4. Brand S (2009) Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut. 58:1152-67.
5. Burckhardt G and Wolff N. (2000) Structure of renal organic anion and cation transporters. Am. J. Physiol. Renal. Physiol. 278:853-866.
6. Cadwell K (2010) Crohn's Disease Susceptibility Gene Interactions, a NOD to the Newcomer ATG16L1. Gastroenterology. 139:1448-1450.
7. Cadwell K, Liu JY, Brown SL, Miyoshi H, Loh J, et al. (2008) A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 456:259-63
8. Cadwell K, Patel KK, Komatsu M, Virgin HW 4th & Stappenbeck, TS (2009) A common role for Atg16L1, Atg5 and Atg7 in small intestinal Paneth cells and Crohn's disease. Autophagy 5:250-2.
9. Cadwell K, Patel K, Maloney N, Liu TC, NG A, Storer C, Head R, Xavier R, Stappenbeck T, and Virgin H. (2010) Virus-Plus-Susceptibility Gene Interaction Determines Crohn's Disease Gene Atg16L1 Phenotypes in Intestine. Cell 141:1135-1145.
10. Church J (2001) Molecular Genetics and Crohn's Disease. Surgical Clinics of North America 81.
11. Cotterill L, Payne D, Levinson S, McLaughlin J, Wesley E, Feeney M, Durbin H, Lal S, Makin A, Campbell S, et al. (2010) Replication and meta-analysis of 13, 000 cases defines the risk for interleukin-23 receptor and autophagy-related 16-like 1 variants in Crohn's disease. J Gastroenterol 24:297-302.
12. Csöngei V, Járomi L, Sáfrány E, Sipeky C, Magyari L, Faragó B, Bene J, Polgár N, Lakner L, Sarlós P (2010) Interaction of the major inflammatory bowel disease susceptibility alleles in Crohn's disease patients. World. J. Gastroenterol. 16:176-83.
13. Deretic V, Master S, and Singh S (2008) Autophagy gives a nod and a wink to the inflammasome and Paneth cells in Crohn's disease. Dev. Cell. 15; 641-2.
14. Duerr R et al. (2006) A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene. Science 314:1461-1463. (Pubitemid 44871953)
15. Duerr R (2007) Genome-Wide Association Studies Herald a New Era of Rapid Discoveries in Inflammatory Bowel Disease Research. Gastroenterology 132:2045-2062.
16. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA (2005) Diversity of the human intestinal microbial flora. Science 308:1635-1638. (Pubitemid 40807514)
17. Einarsdottir E, Koskinen LL, Dukes E, Kainu K, Suomela S, Lappalainen M, Ziberna F, Korponay-Szabo IR, Kurppa K, Kaukinen K, et al. (2009) IL23R in the Swedish, Finnish, Hungarian and Italian populations: association with IBD and psoriasis, and linkage to celiac disease. BMC Med. Genet. 10:8.
18. Elson CO, Cong Y, Weaver CT, Schoeb TR, McClanahan TK, Fick RB, Kastelein RA. (2007) Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. Gastroenterology 132:2359-2370. (Pubitemid 46890867)
19. Fedorak RN and Dieleman LA. (2008) Probiotics in the treatment of human inflammatory bowel diseases. J. Clin. Gastroenterol. 42:97-103.
20. Fernando MM, Stevens CR, Walsh EC, De Jager PL, Goyette P, et al. (2008) Defining the role of the MHC in autoimmunity: a review and pooled analysis. PloS Genet. 4:e1000024
21. Fisher SA, Tremelling M, Anderson CA, Gwilliam R, Bumpstead S, et al. (2008) Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat. Genet. 40:710-12. (Pubitemid 351748865)
22. Franke A, McGovern DP, Barrett JC, Wang K, Radford-Smith GL, Ahmad T, Lees CW, Balschun T, Lee J, Roberts R, et al (2010) Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat. Gen. 42:1118-25.
23. Fransen K, Visschedijk M, Sommeren S, Fu J, Franke L, Festen E, Stokkers P, Bodegrave A, Crusius V, Hommes D, et al. (2010) Analysis of SNPs with an effect on gene expression identifies UBE2L3 and BCL3 as potential new risk genes for Crohn's disease. Hum. Mol. Genet. 19:3482-3488.
24. Fritz T, Niederreiter L, Adoph T, Blumberg R, and Kaser A. (2011) Crohn's disease: NOD2, autophagy and ER stress converge. Gut. doi:10.1136/gut.2009. 206466
25. Fujita N, Saitoh T, Kageyama S, Akira S, Noda T, and Yoshimori T. (2009) Differential involvement of Atg16L1 in Crohn disease and canonical autophagy: analysis of the organization of the Atg16L1 complex in fibroblasts. J. Biol. Chem. 284:32602-9.
26. Glas J, Seiderer J, Wetzke M, Konrad A, Török HP, Schmechel S, Tonenchi L, Grassl C, Dambacher J, Pfennig S, et al. (2007) rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants. PLoS One 2:e819.
27. Glas J, Konrad A, Schmechel S, Dambacher J, Seiderer J, Schroff F, Wetzke M, Roeske D, Török HP, Tonenchi L, et al. (2008) The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population. Am J Gastroenterol 103:682-91. (Pubitemid 351406000)
28. Hamm CM, Reimers MA, McCullough CK, Gorbe EB, Lu J, Gu CC, Li E, Dieckgraefe BK, Gong Q, Stappenbeck, TS. (2010) NOD2 status and human ileal gene expression. Inflamm. Bowel. Dis. 16:1649-57.
29. Hampe J, Franke A, Rosenstiel P, Till A, Teuber M, et al. (2007) A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn's disease in ATG16L1. Nat. Genet. 39:207-11. (Pubitemid 46184351)
30. Hildebrandt MA, Hoffmann C, Sherrill-Mix SA, Keilbaugh SA, Hamady M, Chen YY, Knight R, Ahima RS, Bushman F, and Wu GD (2009) High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 137:1716-24.e1-2.
31. Hradsky O, Dusatkova P, Lenicek M, Bronsky J, Duricova D, Nevoral J, Vitek L, Lukas M, and Cinek O. (2010) Two Independent Genetic Factors Responsible for the Associations of the IBD5 Locus with Crohn's Disease in the Czech Population. Inflamm. Bowel. Dis. 1-7.
32. Hu C, Sun L, Hu Y, Lu D, Wang H, & Tang S. (2010) Functional characterization of the NF-kappaB binding site in the human NOD2 promoter. Cell. Mol. Immuno. 7:288-95. Epub 2010 May 3.
33. Hue S, Ahern P, Buonocore S, Kullberg MC, Cua DJ, McKenzie BS, Powrie F, Maloy KJ (2006) Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J. Exp. Med. 203:2473-2483. (Pubitemid 44664617)
34. Hugot J, Chamaillard M, Zoual H, Lesage S, Cezard J, Belaiche J, Almer S, Tysk C, O'Morain C, Gassull M, et al. (2001) Association of NOD2 leucine rich repeat variants with susceptibility to Crohn's Disease. Nature 411:599-603. (Pubitemid 32531408)
35. Hugot J, Zouali H, and Lesage, S (2003) Lessons to be learned from the NOD2 gene in Crohn's Disease. Eur. J. Gastroenterol. Hepatol. 15:593-597. (Pubitemid 36688221)
36. Hugot J, Chamaillar, M, Zouali H, Lesage S, Cezard J, Belaiche J, Almer S, Tysk C, O'Morain C, Gassull M, et al. (2009) Association of NOD2 leucine rich repeat variants with susceptibility to Crohn's Disease. Nature 411:599-603.
37. Karlinger K, Györke T, Makö E, Mester A, Tarján Z (2000) The epidemiology and the pathogenesis of inflammatory bowel disease. Eur. J. Radiol. 35:154-67.
38. Kim Y, Park J and Shaw M et al. (2008) The cytosolic sensors Nod1 and Nod2 are critical for bacterial recognition and host defense after exposure to Toll-like receptor ligands, Immunity 28:246-257.
39. Kobayashi T, Okamoto S, Hisamatsu T, Kamada N, Chinen H, Saito R, Kitazume M, Nakazawa A, Sugita A, Koganei K, Isobe K, and Hibi T. (2008) IL23 differentially regulates, the TH1/TH17 balance in ulcerative colitis and Crohn's disease. Gut 57:1682-1689.
40. Kosovac K, Brenmoehl J, Hller E, Falk W, Schoelmerich J, Hausmann M & Rogler G. (2010) Association of the NOD2 genotype with bacterial translocation via altered cell-cell contacts in Crohn's disease patients. Inflamm. Bowel. Dis. 16:1311-21.
41. Kuballa P, Huett A, Rioux JD, Daly MJ, Xavier RJ (2008) Impaired autophagy of an intracellular pathogen induced by a Crohn's disease associated ATG16L1 variant. PLos ONE 3:e3391
42. Kullberg MC, Jankovic D, Feng CG, Hue S, Gorelick PL, McKenzie BS, Cua DJ, Powrie F, Cheever AW, Maloy KJ, et al. (2006). IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J. Exp. Med. 203:2485-2494. (Pubitemid 44664618)
43. Lacher M, Schroepf S, Helmbrecht J, von Schweinitz D, Ballauff A, Koch I, Lohse P, Osterrieder S, Kappler R, Koletzko S (2010) Association of the interleukin-23 receptor gene variant rs11209026 with Crohn's disease in German children. Acta. Paediatr. 99:727-33.
44. Lakatos P, Szamosi T, Szilvasi A, Molnar E, Lakatos L, Kovacs A, Molnar T, Altorjay I, Papp M, Tulassay Z, et al. (2008) ATG16L1 and IL23 receptor (IL23R) genes are associated with disease susceptibility in Hungarian CD patients. Dig. Liver. Dis. 40:867-873.
45. Lecat A, Piette J, Legrand-Poels S (2010) The protein NOD2: an innate receptor more complex than previously assumed. Biochem. Pharmacol. 80:2021-31.
46. Lee JC and Parkes M (2011) Genome-wide association studies and Crohn's disease. Brief. Funct. Genomics. 10:71-6.
47. Levine, B (2005) Eating oneself and Univited Guests: Autophagy-Related Pathways in Cellular Defense. Cell 120:159-162. (Pubitemid 40174758)
48. Loftus EV Jr. (2004) Clinical epidemiology of inflammatory bowel disease: incidence, prevalence and environmental influences. Gastroenterology 126:1504-1517. (Pubitemid 38649869)
49. Lichtenstein GR, Hanauer SB, Sandborn WJ (2009) Practice Parameters Committee of the American college of gastroenterology. Am. J. Gastroenterol. 104:465-483.
50. Matthew C (2008) New links to the pathogenesis of Crohn disease provided by genome-wide association scans. Nat. Rev. Genet. 9:9-14.
51. Matzinger P (2002) The danger model: a renewed sense of self. Science 296:301-5. (Pubitemid 34303674)
52. Maynard CL and Weaver CT (2009) Intestinal effector T cells in health and disease. Immunity 31:389-400.
53. McCarroll SA, Huett A, Kuballa P, Chilewski SD, Landry A, Goyette P, Zody MC, Hall JL, Brant SR, Cho JH, Duerr RH et al. (2008) Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nat. Gen. 40:1107-12.
54. McGovern D, Rotter J, Mei L, Haritunians, T, Landers C, Derkowski C, Dutridge D, Dubinsky M, Ippoliti A, Vasiliauska, E et al. (2009) Genetic Epitasis of IL23/IL17 Pathway Genes in Crohn's Disease. Inflamm. Bowel. Dis. 15:883-889.
55. Mitozugchi A and Mizoguchi E (2010) Animal Models of IBD: Linkage to human disease. Curr. Opin. Pharmacol. 10:578-587.
56. Mizoguchi A, Ogawa A, Takedatsu H, Sugimoto K, Shimomura Y, Shirane K, Nagahama K, Nagaishi T, Mizoguchi E, Blumberg RS, et al. (2007) Dependence of intestinal granuloma formation on unique myeloid DC-like cells. J. Clin. Invest. 117:605-615. (Pubitemid 46348519)
57. Molodecky NA and Kaplan GG (2010) Environmental risk factors for inflammatory bowel disease. Gastroenterol. Hepatol. (N Y) 6:339-46.
58. Nell S, Suerbaum S and Josenhans C (2010). The impact of the microbiota on the pathogenesis of IBD. Nat. Rev. Microbiol. 8:564-77.
59. Newman WG, Zhang Q, Liu X, Amos CI, and Siminovitch KA (2009) Genetic variants in IL-23R and ATG16L1 independently predispose to increased susceptibility to Crohn's disease in a Canadian population. J. Clin. Gastroenterol. 43:444-7.
60. Noble CL, Nimmo ER, Drummond H, et al. (2005). The contribution of OCTN1/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn's disease. Gastroenterology 129:1854-1864. (Pubitemid 41772964)
61. Noguchi E, Homma Y, Kang X, Netea M, and Ma X. (2009) A CD associated NOD2 mutation suppresses transcription of human IL10 by inhibiting activity of the nuclear ribonucleoprotein hnRNP-A1. Nat. Immunol. 10:471-479.
62. Ogura Y, Bonen DK, Inohara N et al. (2001). A frameshift mutation in NOD2 association with susceptibility to Crohn's disease. Nature 411:599-603.
63. Palomino-Morales, RJ, Gomez-Garcia, M, Lopez-Nevot, MA, Rodrigo, L, Nieto, A, Alizadeh, BZ, and Martin, J (2009) Association of ATG16L1 and IRGM genes polymorphisms with inflammatory bowel disease: a meta-analysis approach. Genes. Immun. 10:356-364.
64. Peltekova VD, Wintle RF, Rubin LA et al. (2004) Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat. Genet. 36:471-475. (Pubitemid 38620030)
65. Podolsky DK (2002) Inflammatory bowel disease. N Engl J Med 347:417-29. (Pubitemid 34851835)
66. Ramsay RR (2000) The carnitine acyltransferases: modulators of acyl-CoA-dependent reactions. Biochem. Soc. Trans. 28:182-186. (Pubitemid 30103237)
67. Reinhard C and Rioux J (2006) Role of the IBD5 Susceptibility Locus in the Inflammatory Bowel Diseases. Inflamm. Bowel. Dis. 12:227-238.
68. Repnik K. and Potocniki U (2010) CTLA3 CT60 Single-Nucleotide Polymorphism is Associated with Slovenian Inflammatory Bowel Disease Patients and Regulates Expression of CTLA4 Isoforms. DNA Cell Biol 00:1-8.
69. Rioux JD, Silverberg MS, Daly MJ et al. (2000) Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am. J. Hum. Genet. 66:1863-1870. (Pubitemid 30480093)
70. Roediger W and Nance S (1986) Metabolic induction of experimental ulcerative colitis by inhibition of fatty acid oxidation. Br. J. Exp. Pathol. 67:773-782. (Pubitemid 17212913)
71. Sabbah A, Chang TH, Harnack R, Frohlich V, Tominaga K, Dube PH, Xiang Y, and Bose S (2009) Activation of innate immune antiviral responses by Nod2. Nat. Immunol. 10:1073-80.
72. Silverberg M, Duerr R, Brant S, Bromfield G, Datta L, Jani N, Kane S, Rotter J, Schumm P, Steinhart H, et al. (2007) Refined genomic localization and ethnic differences observed for the IBD5 association with Crohn's disease. Eur. J. Hum. Genet. 15:328-335.
73. Singh SB, Davis AS, Taylor GA, and Deretic V (2006) Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science 313:1438-41. Epub 2006 Aug. 3. (Pubitemid 44360272)
74. Stappenbeck T, Rioux J, Mizoguchi A, Saitoh T, Huett A, Darfeuille-Michaud A, Wileman T, Mizushim N, Carding S, Akira S, et al. (2010) Crohn Disease: A current Perspective on Genetics, Autophagy and Immunity. Autophagy 7:1-20.
75. Swoger JM and Binion, DG (2010) Supportive therapy in IBD: what additional diagnoses and conditions must be treated? Dig. Dis. 28:452-62.
76. Taylor KD, Targan SR, Mei L, Ippoliti AF, McGovern D, Mengesha E, King L, Rotter JI (2008) IL23R haplotypes provide a large population attributable risk for Crohn's disease. Inflamm. Bowel. Dis. 14:1185-91.
77. Tokuhiro S, Yamada R, Chang X, Suzuki A, Kochi Y, Sawada T, Suzuki M, Nagasaki m, Ohtsuki M, Ono M et al. (2003) An Intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat. Genet. 35:341-8. (Pubitemid 37486917)
78. Travassos LH, Carneiro LA, Ramjeet M, Hussey S, Kim YG, Magalhães JG, Yuan L, Soares F, Chea E, Le Bourhis L, et al. (2010). Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat. Immunol. 11:55-62.
79. Tysk C, Lindberg E, Järnerot G, and Flodérus-Myrhed B (1988) Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins; A study of heritability and the influence of smoking. Gut 29:990-6.
80. Uhlig HH, McKenzie BS, Hue S, Thompson C, Joyce-Shaikh B, Stepankova R, Robinson N, Buonocore S, Tlaskalova-Hogenova H, Cua DJ, Powrie F (2006) Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 25:309-318.
81. van Heel DA, Fisher SA, Kirby A, Daly MJ, Rioux JD, et al. (2004) Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. Hum. Mol. Genet. 13:763-70. (Pubitemid 38455963)
82. Van Limbergen J, Russell RK, Nimmo ER, Drummond HE, Smith L, Anderson NH, Davies G, Gillett PM, McGrogan P, Weaver LT, et al. (2008) Autophagy gene ATG16L1 influences susceptibility and disease location but not childhood-onset in Crohn's disease in Northern Europe. Inflamm. Bowel. Dis, 14:338-46. (Pubitemid 351441322)
83. Van Limbergen, J, Wilson, D, and Satsangi, J (2009) The Genetics of Crohn's Disease. Annu. Rev. Genomics. Hum. Genet. 10; 89-116.
84. Wang, K, Zhang, H, Kugathasan, S, Annese, V, Bradfield, J, Russel, R, Sleiman, P, Imielinski, M, Glessner, J, Hou, C, et al. (2009) Diverse Genome-wide Association Studies Associate the IL12/IL23 Pathway with Crohn Disease. Am. J. Hum. Genet. 84:399-405.
85. Xavier R and Podolsky DK (2005) Commensal flora: wolf in sheep's clothing. Gastroenterology 128:1122-6. (Pubitemid 40523563)
86. Xavier RJ and Podolsky DK (2007). Unravelling the pathogenesis of inflammatory bowel disease. Nature 448:427-34. (Pubitemid 47123518)
87. Xavier R (2008) Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nat. Gen. 4:1107-1112.
88. Zenhzhirong C, Xiaoqin W, Minhu C, Mei L, Xiang G, Baili C, and Pinjin H (2009) Contribution of rs11465788 in IL23R gene to Crohn's disease susceptibility and phenotype in Chinese population. J. Genet 88:191-196.